Document:

Exhibit
10.7

 

NEGOTOIABLE 

SECURED
PROMISSORY NOTE

 

	 $600,000.00	September 16, 2021

  Phoenix, AZ

  

For
value received RIVULET FILMS, INC., a Delaware corporation, (“Payor”) hereby promises to pay to TOPPS,
LLC, an Arizona limited liability company and/or Nominee (“Holder”) at 11575 North 87th Place, Scottsdale,
Arizona 85260, or at such other address as Holder may designate, the principal sum of $600,000.00 together with interest at the rate
of nineteen percent (19%) per annum as described below.

 

1.       Term.
Any and all sums due hereunder shall be due and payable on or before September 16, 2022 (“Maturity Date”).

 

2.       Payments.
All payments of interest and principal shall be in lawful money of the United States of America.

 

3.       Use
of Fundsu Payor represents, warrants and covenants that the monetary funds advanced by Holder shall be used for general business
purposes.

 

4.       Interest,
Fees and Principal Payments.

 

4.1       Payor
shall pay a consulting fee to IPCC, LLC, in an amount equal to 5% of the principal amount of the Note, or $30,000, as well as Holder’s
attorney’s fees in the amount of $6,000.00, to be paid at the commencement date of the Note.

 

4.2       Payor
shall prepay twelve (12) months of interest in the aggregate amount of $114,000.00 to Holder, to be paid at the commencement date of
the Note.

 

4.3       Holder
will “net fund” the amount of $450,000.00 to Payor.

 

4.4       Payor
shall remit payment of the net principal $600,000.00 to Holder on or before the Maturity Date.

 

5.       Default.
In the Event of Default (as defined below) hereunder, at the option and upon the declaration of the Holder of this Note and upon
five (5) days written notice to Payor (which election and notice shall not be required in the case of an Event of Default under Section
5.2 or 5.3 below), this Note shall accelerate, and all principal and unpaid accrued interest shall become immediately due, payable and
collectible. Default interest shall accrue on the unpaid principal amount outstanding as of the Event of Default at the rate equal to
twenty-five percent (25%) until paid in full. The occurrence of any one or more of the following shall constitute an “Event
of Default” hereunder:

 

5.1       Payor
fails to pay timely any sum when due under this Note on the date the same becomes due and payable;

 

5.2       Payor
files any petition or action for relief under any bankruptcy, reorganization, insolvency or moratorium law or any other law for the relief
of, or relating to, debtors, now or hereafter in effect, or makes any assignment for the benefit of creditors or takes any corporate
action in furtherance of any of the foregoing;

     

     

    

5.3       An
involuntary petition is filed against Payor (unless such petition is dismissed or discharged within sixty (60) days under any bankruptcy
statute now or hereafter in effect, or a custodian, receiver, trustee, assignee for the benefit of creditors (or other similar official)
is appointed to take possession, custody or control of any property of Payor; or,

 

5.4       The
violation or act of default under the terms and conditions of the Collateral Security Agreements.

 

6.       Security
Interest. This Note shall be secured by the assignment of certain film rights pursuant to Collateral Security Agreements from
Payor and its wholly owned subsidiaries: PBP Productions, LLC and Mistress Movie, LLC.

 

7.       Negotiable.
This Note is fully negotiable, in whole or in part, without the prior written consent of Payor.

 

8.       Attorneys’
Fees. In any litigation or other proceeding in connection with the interpretation of this Note, or the exercise or enforcement
of any right under this Note, the non prevailing party shall pay or reimburse the prevailing party for all expenses, including court
costs and attorneys’ fees, incurred by the prevailing party in connection with such litigation or proceeding (whether incurred at the
trial, appellate, or administrative levels, and in any bankruptcy case, arbitration or other proceeding), all of which may be incorporated
into and be a part of any judgment or decision rendered in such proceeding.

 

9.       Waiver
of Notice. Payor hereby waives demand, notice, presentment, protest and notice of dishonor.

 

10.       Governing
Law. This Note shall be governed by construed under the laws of the State of Arizona, without giving effect to conflicts of laws
principles.

 

11.       Amendment;
Waiver. Any term of this Note may be amended and the observance of any term of this Note may be waived (either generally or in
a particular instance and either retroactively or prospectively), only with the written consent of the Payor and Holder. Any amendment
or waiver effected in accordance with this paragraph shall be binding upon the Payor and Holder.

 

	PAYOR:	 
	 	 	 
	Rivulet Films, Inc.,	 
	a Delaware corporation	 
	 	 	 
	By:	/s/
    Michael Witherill	 
	 	Its:
    PresidentExhibit 10.8

 

STOCK
SALE AGREEMENT

 

This
Stock Sale Agreement (this “Agreement”) is dated September 27, 2021 (the “Effective Date”), between
Rivulet Media, Inc., a Delaware corporation with an address of 1206 E Warner Rd, Suite 101-I, Gilbert, AZ 85296 (“Seller”),
and Michael Witherill, an individual with an address of 1206 E Warner Rd, Suite 101-I, Gilbert, AZ 85296 (“Purchaser”).
The parties hereby agree as follows:

 

RECITALS

 

A.       Seller
is the owner of 29,076,665 shares of common stock and 2,907,666 shares of Series A Preferred Stock (together, the “Regen Shares”)
of Regen BioPharma, Inc. (the “Regen BioPharma”).

 

B.       Seller
desires to sell and transfer, and Purchase desires to purchase, all of the Regen Shares on the terms and conditions set forth herein.

 

NOW
THEREFORE, in consideration of promises, mutual covenants, and undertakings herein and other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the parties hereby agree as follows:

 

AGREEMENTS

 

1.               
Sale and Assignment of Regen Shares. Subject to the terms of this Agreement, effective as of the Effective Date, the Seller hereby
sells, assigns, and transfers to Purchaser, and Purchaser agrees to purchase from each Seller, the Regen Shares, free and clear of all
encumbrances.

 

2.               
Purchase Price. As consideration for the purchase of the Regen Shares, Purchaser shall pay to Seller the aggregate amount of proceeds
actually received by Purchaser resulting from Purchaser’s subsequent sale of the Regen Shares on the open market in one or more
at-the-market transactions, which amount is expected to equal approximately $1,400,000. The parties will execute a Loan Agreement and
Promissory Note to evidence the obligation to make the payments set forth herein. 

 

3.               
Taxes. Seller agrees to pay all taxes associated with the sale of the Regen Shares, whether incurred by Seller or by Purchaser
as a result of Purchaser’s subsequent sale of the Regen Shares on the open market.

 

4.               
Representations and Warranties of Seller. Seller represents and warrants to Purchaser that: (a) the Regen Shares have not been
assigned, sold, mortgaged, or pledged to any other person or entity, and Seller has all right, title, and interest in and to the Regen
Shares free and clear of all liens, charges, mortgages or security interests; (b) no person or entity whatsoever has any claim, right,
title, interest, or lien in, to, or on the Regen Shares; and (c) Seller has full authority to sell, assign, and transfer the Regen Shares.

 

5.               
Representations and Warranties of Purchaser. Purchaser represents and warrants to Seller that: (a) Purchaser has had an opportunity
to conduct due diligence regarding the value of the Regen Shares and the operations and financial condition of Regen BioPharma as deemed
appropriate by Purchaser to satisfy himself of the condition of the Regen BioPharma and is relying upon his review and investigation
thereof and not upon any representation or statement of the Seller or any other person, firm, or corporation; and (b) Purchaser has full
authority to enter into this Agreement and acquire the Regen Shares.

     

     

    

6.               
Attorneys’ Fees. In the event of any action or proceeding to compel compliance with, or for a breach of, any of the terms
and conditions of this Agreement, the substantially prevailing party shall be entitled to recover from the non-prevailing party the costs
of such action or proceedings, including, without limitation, reasonable attorneys’ fees, costs and disbursements.

 

7.               
Additional Instruments. Each party, promptly upon the request of any other party, shall sign and have acknowledged and delivered
to the other party as may be appropriate, any and all additional instruments and assurances reasonably requested or appropriate to evidence
or give effect to the provisions of this Agreement.

 

8.               
General Provisions. 

 

    (a)             
This Agreement shall be governed by and construed in accordance with the laws of the State of Arizona.

 

    (b)            
This Agreement sets forth the complete and entire understanding of the parties hereto, and supersedes any prior agreement, with respect
to the subject matter hereof and may not be modified, amended, or otherwise altered except in writing executed by the parties.

 

    (c)             
This Agreement may be executed in multiple counterparts, each of which shall be deemed an original and all of which taken together shall
constitute one and the same instrument.

 

IN
WITNESS WHEREOF, the undersigned have executed this Stock Sale Agreement as of the date set forth above.

 

	 	PURCHASER
	 	 	 
	 	/s/
    Michael Witherill
	 	Michael
    Witherill
	 	 	 
	 	SELLER
	 	Rivulet
    Media, Inc.,
	 	a
    Delaware corporation
	 	 	 
	 	By: 	/s/
    Michael Witherill
	 	 	Michael
    Witherill, President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]